News
Slew of Flaring Incidents Reported at Los Angeles Refineries
Recent flaring incidents at Los Angeles refineries have raised concerns and prompted investigations. The incidents involve unplanned flaring events, release of sulfur dioxide, and scheduled maintenance work. The South Coast Air Quality Management District is closely monitoring the situation. Meanwhile, the market price of Los Angeles CARBOB remains stable.
Read moreRivian's Challenges in the EV Market
Rivian may face challenges in meeting volume targets and achieving gross margin profitability as demand softens and pricing risks increase. Analyst downgrades stock rating but acknowledges long-term potential.
Read moreBig Lots Stock Downgraded Amid Financial Concerns
Loop Capital analyst downgrades Big Lots stock as the company faces a precarious financial situation and seeks new financing options. Stock is down 12% in premarket trading.
Read moreExpedia's Stock Hits Lowest Point in Three Months After CEO Change
Expedia's stock hits lowest point in three months after surprise CEO change, leading to concerns and downgrades from analysts. Despite some optimism, challenges lie ahead for the company as it undergoes strategic changes.
Read moreAMMO Sees Rise in Stock After Narrowing Losses in Q3
AMMO, a Scottsdale-based company, sees a rise in stock prices after narrowing losses in the third quarter. Improved profit margins and positive demand for ammunition contribute to the positive outlook.
Read moreBBB Foods Inc.: The Mexican Supermarket Chain's Exciting IPO
BBB Foods Inc. announces its IPO pricing and details, reflecting strong investor interest and generating impressive proceeds. Investors gain a stake in a business with promising growth potential in the Mexican supermarket chain.
Read moreCatalent Reports Loss in Q2 Amid Sales Decline
Catalent, a contract drug manufacturer, experienced a significant loss in its fiscal second quarter as sales decreased and margins weakened. Revenue dropped 10% to $1.03 billion, falling short of analyst forecasts of $1.36 billion. Categories: Business, Pharmaceuticals, Finance. Tags: Catalent, Q2 loss, sales decline, margins weakened. Keywords: contract drug manufacturer, fiscal Q2, revenue decrease, analyst forecasts, Covid-19 related programs.
Read moreAsia-Pacific Stocks Experience Mixed Performance
The Asia-Pacific stock market saw a mix of gains and losses, with Hong Kong's Hang Seng Index declining while the Japanese market showed gains. Other markets in Singapore, China, South Korea, and Australia also experienced fluctuations.
Read moreEnbridge Fights to Keep Pipeline Running through Wisconsin Tribal Reservation
Enbridge battles in court to keep a pipeline running through a tribal reservation in Wisconsin, while the Bad River tribe seeks action to protect against potential spills and urges the shutdown of the pipeline.
Read moreInflation Revisions: Preparing for Potential Changes
Investors brace for the release of inflation revisions, which could have significant implications. Experts share insights on what to expect.
Read more